Atlas Trials

Methylphenidate vs. Risperidone for the Treatment of Children and Adolescents With ADHD and Disruptive Disorders

Clinical trial NCT02063945 · TERMINATED

Trial details

NCT number
NCT02063945
Sponsor
Sheba Medical Center
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Attention Deficit/Hyperactivity DisorderOppositional Defiant DisorderConduct Disorder
Start date
2017-02-01
Primary completion
2018-02-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.